Synthesis, activity evaluation, and pro-apoptotic properties of novel 1,2,4-triazol-3-amine derivatives as potent anti-lung cancer agents

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Wang Q, Ma C, Li X, et al. Synthesis of novel sugar or azasugar modified anthra[1,2-d]imidazole-6,11-dione derivatives and biological evaluation. Carbohydrate Res 2018;460:29–33.
   PubMed Web of Science ®Google Scholar
• Gazieva GA, Anikina LV, Nechaeva TV, et al. Synthesis and biological evaluation of new substituted thioglycolurils, their analogues and derivatives. Eur J Med Chem 2017;140:141–54.
   PubMed Web of Science ®Google Scholar
• Osmaniye D, Kaya Cavusoglu B, Saglik B, et al. Synthesis and anticandidal activity of new imidazole-chalcones. Molecules 2018;23:831.
   Web of Science ®Google Scholar
• Liu Y, Peng Y, Lu J, et al. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2′-deoxy-2′-fluoro-4′-azido nucleoside derivatives as potent anti-HBV agents. Eur J Med Chem 2018;143:137–49.
   PubMed Web of Science ®Google Scholar
• Hafez HN, Alsalamah SA, El-Gazzar AR. Synthesis of thiophene and N-substituted thieno [3,2-d] pyrimidine derivatives as potent antitumor and antibacterial agents. Acta Pharm 2017;67:275–92.
   PubMed Web of Science ®Google Scholar
• Abdou WM, Ganoub NA, Sabry E. Design, synthesis and pharmacological screening of β-amino-, thiadiazole/thiadiazine-phosphonate based triazole motifs as antimicrobial/cytotoxic agents. Acta Pharm 2014;64:267–84.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xia Y, Fan Y, et al. N-Aryltriazole ribonucleosides with potent antiproliferative activity against drug-resistant pancreatic cancer. Bioorganic Med Chem Letters 2010;20:2503–7.
   PubMed Web of Science ®Google Scholar
• Çıkla-Süzgün P, Kaushik-Basu N, Basu A, et al. Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles. J Enzyme Inhib Med Chem 2015;30:778–85.
   PubMed Web of Science ®Google Scholar
• Mustafa M, Abdelhamid D, Abdelhafez EMN, et al. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues. Eur J Med Chem 2017;141:293–305.
   PubMed Web of Science ®Google Scholar
• Ohsumi K, Hatanaka T, Fujita K, et al. Syntheses and antitumor activity of cis-restricted combretastatins: 5-membered heterocyclic analogues. Bioorg Med Chem Lett 1998;8:3153–8.
   PubMed Web of Science ®Google Scholar
• Driowya M, Leclercq J, Verones V, et al. Synthesis of triazoloquinazolinone based compounds as tubulin polymerization inhibitors and vascular disrupting agents. Eur J Med Chem 2016;115:393–405.
   PubMed Web of Science ®Google Scholar
• Alanazi AM, Abdel-Aziz AAM, Shawer TZ, et al. Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies. J Enzyme Inhib Med Chem 2016;31:721–35.
   PubMed Web of Science ®Google Scholar
• Fodor M, Price E, Wang P, et al. Dual allosteric inhibition of SHP2 phosphatase. ACS Chem Biol 2018;13:647–56.
   PubMed Web of Science ®Google Scholar
• Ferrini S, Chandanshive JZ, Lena S, et al. Ruthenium-catalyzed synthesis of 5-amino-1,2,3-triazole-4-carboxylates for triazole-based scaffolds: beyond the Dimroth rearrangement. J Org Chem 2015;80:2562–72.
   PubMed Web of Science ®Google Scholar
• Shao B, Wei X, Luo M, et al. Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis. Sci Rep 2015;5:16437.
   PubMed Web of Science ®Google Scholar
• Luan Z, He Y, He F, et al. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein down regulation. Mol Med Rep 2015;11:203–11.
   PubMed Web of Science ®Google Scholar
• Hany AME, Bahaa GMY, Syed NAB, et al. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors. Eur J Med Chem 2018;156:774–89.
   PubMed Web of Science ®Google Scholar
• Dantale S, Reboul V, Metzner P, et al. First use of axially chiral thioamides for the stereocontrol of C-C bond formation. Chem A Eur J 2002;8:632–40.
   PubMed Web of Science ®Google Scholar
• Yang CH, Li GJ, Gong CJ, et al. N, N-dialkylaniline-assisted thionation of carboxylic amides and esters. Tetrahedron 2015;71:637–42.
   Web of Science ®Google Scholar
• Zhang HJ, Zhang GR, Piao HR, et al. Synthesis and characterisation of celastrol derivatives as potential anticancer agents. J Enzyme Inhib Med Chem 2018;33:190–8.
   PubMed Web of Science ®Google Scholar
• Sun XY, Zhong CY, Liu MY, et al. Design, synthesis and activity evaluation of 2-ethyl-1-(4-substituted) phenyl-1H-imidazole derivatives as potent antibacterial agents. Latin Am J Pharmacy 2018;37:768–74.
   Web of Science ®Google Scholar
• Nishida H, Arikawa Y, Hirase K, et al. Identification of a novel fluoropyrrole derivative as a potassium-competitive acid blocker with long duration of action. Bioorg Med Chem 2017;25:3298–314.
   PubMed Web of Science ®Google Scholar
• Meng LQ, Liu C, Luo YH, et al. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways. Mol Med Rep 2018;17:2626–34.
   PubMed Web of Science ®Google Scholar
• Wang JR, Shen GN, Luo YH, et al. The compound 2-(naphthalene-2-thio)-5, 8-dimethoxy-1,4-naphthoquinone induces apoptosis via reactive oxygen species‐regulated mitogen-activated protein kinase, protein kinase B, and signal transducer and activator of transcription 3 signaling in human gastric cancer cells. Drug Dev Res 2018;79:295–306.
   PubMed Web of Science ®Google Scholar
• Wang F, Wei ZL, Sun XR, et al. Apoptosis inducing factor is involved in stretch-induced apoptosis of myoblast via a caspase-9 independent pathway. J Cell Biochem 2017;118:829–38.
   PubMed Web of Science ®Google Scholar
• Hassan M, Watari H, AbuAlmaaty A, et al. Sakuragi, apoptosis and molecular targeting therapy in cancer. BioMed Res Int 2014;2014:1–23.
   Web of Science ®Google Scholar
• Melissa DA, Gunning PW, Stehn JR. Tumor suppressor tropomyosin Tpm2. 1 regulates sensitivity to apoptosis beyond anoikis characterized by changes in the levels of intrinsic apoptosis proteins. Cytoskeleton 2017;74:233–48.
   PubMed Web of Science ®Google Scholar